1980
DOI: 10.1016/s0001-2092(07)61557-9
|View full text |Cite
|
Sign up to set email alerts
|

Research language

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2002
2002
2002
2002

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…156 Similarly, the FDA requirements for informing PB recipients, for record keeping, and for post-treatment follow-up were not met. 157 These failures to comply with conditions of the FDA waiver would serve to seriously erode public trust and to question the validity of the decision for the Interim Rule.…”
mentioning
confidence: 99%
“…156 Similarly, the FDA requirements for informing PB recipients, for record keeping, and for post-treatment follow-up were not met. 157 These failures to comply with conditions of the FDA waiver would serve to seriously erode public trust and to question the validity of the decision for the Interim Rule.…”
mentioning
confidence: 99%